Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy.

Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy.
复制标题

单核细胞与高密度脂蛋白胆固醇比率与糖尿病视网膜病变的关联

DOI:
10.3389/fcvm.2021.707008
复制
发表时间:
2021
影响因子:
3.6
通讯作者:
Chen Y
Chen Y
中科院分区:
医学3区
文献类型:
--
作者:
Tang X;Tan Y;Yang Y;Li M;He X;Lu Y;Shi G;Zhu Y;Nie Y;Li H;Mu P;Chen Y

文献摘要

被引文献

相似文献

背景:2型糖尿病(T2 DM)的慢性炎症是糖尿病视网膜病变(DR)发展的重要因素。单核细胞与高密度脂蛋白胆固醇(HDL-C)比值(MHR)是一种与炎症和氧化应激状态相关的新的简单测量方法。然而,鲜为人知的是,关于MHR在评估DR的发展的作用。方法:共有771例T2 DM患者和607名健康对照者参加了这项横断面研究。进行MHR测定和眼部检查。分析T2 DM患者MHR与DR患病率的关系。结果:DR组MHR明显高于非DR组(P < 0.05)和健康对照组(P < 0.01)。不同DR严重程度的MHR差异无统计学意义。此外,非黄斑水肿患者和黄斑水肿患者的MHR相似。Logistic回归分析显示,MHR与糖尿病患者DR的发生独立相关[OR = 1.438,95% CI:1.249-1.655,P < 0.01]。通过HbA 1c水平和糖尿病病程进行分层后,MHR仍与DR的患病率独立相关。结论:我们的研究表明,MHR可作为T2 DM患者DR患病率的标志物。
Background: Chronic inflammation in type 2 diabetes mellitus (T2DM) is an essential contributor to the development of diabetic retinopathy (DR). The monocyte–to–high-density lipoprotein cholesterol (HDL-C) ratio (MHR) is a novel and simple measure related to inflammatory and oxidative stress status. However, little is known regarding the role of the MHR in evaluating the development of DR. Methods: A total of 771 patients with T2DM and 607 healthy controls were enrolled in this cross-sectional study. MHR determination and eye examination were performed. The association of MHR with the prevalence of DR in T2DM patients was analyzed. Results: The MHR in patients with DR was significantly higher than that in both non-DR diabetic patients (P < 0.05) and healthy controls (P < 0.01). No significance was observed in the MHR of different DR severity grades. Moreover, the MHR was similar between patients with non-macular oedema and those with macular oedema. Logistic regression analysis demonstrated that MHR was independently associated with the prevalence of DR in diabetic patients [odds ratio (OR) = 1.438, 95% confidence interval (CI): 1.249–1.655, P < 0.01]. After additional stratification by HbA1c level and diabetic duration, the MHR was still independently associated with the prevalence of DR. Conclusions: Our study suggests that the MHR can be used as a marker to indicate the prevalence of DR in patients with T2DM.